MULTICENTER PHASE III RANDOMIZED TRIAL OF POLY-CHEMOTHERAPY (CVD REGIMEN) VERSUS THE SAME CHEMOTHERAPY (CT) PLUS SUBCUTANEOUS (SC) INTERLEUKIN-2 (IL-2) AND INTERFERON-2B (IFN) IN METASTATIC MELANOMA


    loading  Checking for direct PDF access through Ovid

Abstract

Abstract unavailable for this article.


    loading  Loading Related Articles